Ophthalmology Department Receives $100,000 for Research Initiatives
The UC department of ophthalmology has been awarded a $100,000 grant from Research to Prevent Blindness (RPB) to support ongoing and new clinical and laboratory research.
RPB is a voluntary health organization that supports eye research directed at the prevention, treatment and eradication of vision-threatening diseases. To date, the organization has awarded grants totaling $1,486,750 to UC's College of Medicine.
James Augsburger, MD, chair of the department of ophthalmology, says the grant will assist research looking at corneal wound healing, corneal stem cell transplantation, age-related macular degeneration, intraocular tumors, and retinal development disorders.
"RPB-sponsored research in these areas has resulted in innovative new approaches to treatment of corneal diseases that have improved patient visual outcomes substantially in recent years," he says.
For more information, visit
.
Winston Whei-Yang Kao, PhD, department of ophthalmology
Hongshan Liu, MD, PhD, assistant professor of research in the department of ophthalmology
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.